Purchase of INSTI HIV-1/HIV-2 Antibody Tests for Early HIV Detection

Background

The Florida Department of Health (FDOH), specifically the Bureau of Communicable Disease, is seeking to purchase INSTI HIV-1/HIV-2 Antibody Tests. The goal of this contract is to enable earlier detection of HIV, which can occur up to 9 days sooner than traditional methods such as the Western Blot. This early detection is crucial for providing immediate medical care and preventing the transmission of HIV, thereby protecting public health and curbing the spread of disease.

Work Details

The contract involves the purchase of INSTI HIV-1/HIV-2 Antibody Tests from BioLytical Laboratories Inc. These tests are unique as they are the only FDA-approved rapid tests that can deliver results in just 60 seconds. The specific commodity required falls under the United National Standard Products and Services Code (NSPSC) 41116164, which pertains to test kits or probes for laboratory proficiency assessment. The estimated quantity for this purchase is for a term of 1 year, with an estimated dollar amount of $75,000.

Period of Performance

The contract will be performed over a period of 1 year.

Place of Performance

The products will be delivered to the Florida Department of Health, specifically at their location in Tallahassee, FL.

Bidder Requirements

This procurement is intended as a single source purchase from BioLytical Laboratories Inc., which is the sole manufacturer and provider of the INSTI HIV-1/HIV-2 Antibody Test.